Winners and losers under bold Trump plan to slash drug rebate deals
By
Jay Hancock
Published
5 Min Read
Jay Hancock
From
Kaiser Health News
More From Employee Benefit News
With GLP-1s raising costs, employers are finding new ways to reduce spending
As healthcare expenses approach double-digit increases, employers are looking for savings in waste, care delivery, and plan administration before cutting benefits.
How personalized healthcare guidance can stretch premium dollars
MetLife’s president of U.S. business shares why improving employees’ benefits literacy results in them making smarter choices for their health and financial wellness.
What the 2027 ACA marketplace proposal means for employers
While the legislation's future is still unclear, there are many important things for leaders to know.
Forging stronger broker-TPA partnerships
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
